In addition, we demonstrated that iPSC-based therapy can ameliorate hyperoxia-augmented high VT-induced ALI by suppressing oxidative stress, inflammation, and apoptosis through Src-dependent signaling pathway. The gene discussed is SRC; the disease is acute respiratory distress syndrome.